Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma

Name: Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma
License: Public Domain

Elvira Umyarova

ClinicalTrials.gov · Datasets · License: Public Domain

recurrent multiple myeloma, refractory multiple myeloma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 201786
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.